Opeyemi Olabisi (@opeyemiolabisi8) 's Twitter Profile
Opeyemi Olabisi

@opeyemiolabisi8

Duke Physician-Scientist, Nephrologist whose Lab focuses on APOL1 research and podocyte biology.

ID: 832586890784153601

linkhttps://dmpi.duke.edu/opeyemi-olabisi-md-phd-0 calendar_today17-02-2017 13:45:58

699 Tweet

790 Followers

339 Following

rFSGS Initiative (@rfsgsinitiative) 's Twitter Profile Photo

Do you, a family member, or someone you know have recurrent FSGS? We are hosting a conference regarding recurrent FSGS with leading doctors, patients, and families. Please view our website and register: scgcorp.com/rFSGS2024/ #rFSGS #rFSGSConference

Do you, a family member, or someone you know have recurrent FSGS? We are hosting a conference regarding recurrent FSGS with leading doctors, patients, and families. Please view our website and register: scgcorp.com/rFSGS2024/
#rFSGS #rFSGSConference
rFSGS Initiative (@rfsgsinitiative) 's Twitter Profile Photo

The Recurrent Focal Segmental Glomerulosclerosis Conference will take place on Monday, Dec. 9, in Washington, DC. Our #rFSGSConference will gather patients, doctors, researchers, & funders to raise awareness of #rFSGS, share info, & facilitate funding. scgcorp.com/rFSGS2024/

The Recurrent Focal Segmental Glomerulosclerosis Conference will take place on Monday, Dec. 9, in Washington, DC. Our #rFSGSConference will gather patients, doctors, researchers, & funders to raise awareness of #rFSGS, share info, & facilitate funding. scgcorp.com/rFSGS2024/
Kidney Health Initiative (@kidneyhealthin) 's Twitter Profile Photo

Despite the need for clinical studies to treat APOL1 Kidney Disease, individuals of African ancestry remain underrepresented due to disparities & mistrust. Join KHI for a webinar on empowering patients to participate in clinical studies: bit.ly/3Z3oJJ9​ #KidneyHealth

Despite the need for clinical studies to treat APOL1 Kidney Disease, individuals of African ancestry remain underrepresented due to disparities & mistrust. Join KHI for a webinar on empowering patients to participate in clinical studies: bit.ly/3Z3oJJ9​ #KidneyHealth
Leonardo V. Riella (@lvriella) 's Twitter Profile Photo

🚨Excited to share our work on a new CRISPR-based #pointofcare test to detect high-risk #APOL1 variants. Precise, quick and cheap test, without the need of any machine. Goal to bring #PrecisionMedicine to the bedside! Great collab with Michael Kaminski Lab embopress.org/doi/full/10.10…

🚨Excited to share our work on a new CRISPR-based #pointofcare test to detect high-risk #APOL1 variants. Precise, quick and cheap test, without the need of any machine. Goal to bring #PrecisionMedicine to the bedside! Great collab with <a href="/KaminskiLab/">Michael Kaminski Lab</a>  embopress.org/doi/full/10.10…
International Society of Glomerular Disease (@isgdtweets) 's Twitter Profile Photo

We're expanding our team! Now hiring for a project manager to join our small-but-mighty staff in support of ISGD's strategic projects. This is a full-time, remote, US-based position. is-gd.org/careers

SSC_Lab 🧬 (@sannacherchilab) 's Twitter Profile Photo

Exciting! The preliminary program for our first #rFSGSConference is out! Go check out our dense schedule, share the word with all your patients and families affected by #rFSGS and don’t forget to register! More news and information will keep coming #RareDisease #FSGS

JASN_News (@jasn_news) 's Twitter Profile Photo

Peer review is vital to publishing high-quality, valid research. JASN wants to recognize the top reviewers of 2024: Drs. Alessandra Boletta, Edouard L. Fu, Reiko Inagi, and Opeyemi Olabisi. Each day this week, we'll share their thoughts on peer review. bit.ly/JASNRECOGNITION

Opeyemi Olabisi (@opeyemiolabisi8) 's Twitter Profile Photo

It is gratifying to be recognized as a top reviewer for JASN in 2024. Perhaps, I’ll be off the hook in 2025🤷🏽‍♂️🤓

JASN_News (@jasn_news) 's Twitter Profile Photo

.Opeyemi Olabisi, a 2024 Top 5 reviewer, shared that "JASN attracts highly significant manuscripts from some of the most innovative investigators around the globe. It has been my pleasure to review some of these manuscripts." #PeerReviewWeek

.<a href="/OpeyemiOlabisi8/">Opeyemi Olabisi</a>, a 2024 Top 5 reviewer, shared that "JASN attracts highly significant manuscripts from some of the most innovative investigators around the globe. It has been my pleasure to review some of these manuscripts."
#PeerReviewWeek
rFSGS Initiative (@rfsgsinitiative) 's Twitter Profile Photo

Register for our #rFSGSConference to hear from Opeyemi Olabisi, M.D., Ph.D.! He is an Associate Professor of Medicine at Duke University School of Medicine who specializes in adult nephrology and is dedicated to advancing our understanding of APOL1 nephropathy through innovative research. #rFSGS

Register for our #rFSGSConference to hear from Opeyemi Olabisi, M.D., Ph.D.! He is an Associate Professor of Medicine at <a href="/DukeMedSchool/">Duke University School of Medicine</a> who specializes in adult nephrology and is dedicated to advancing our understanding of APOL1 nephropathy through innovative research. #rFSGS
NEJM Journal Watch (@jwatch) 's Twitter Profile Photo

Dr. Meghan Sise and Dr. Opeyemi Olabisi, NEJM Group's guides for #KidneyWk, talk to Ali S. Raja, MD about what topics will generate the most excitement at the conference. Watch the 10-minute video: jwat.ch/4dZddlN

Leticia Rolon (@leticiarolonmd) 's Twitter Profile Photo

Day 3 of American Society of Nephrology STARS #KidneyWk program continuing with our special session Bridging the Gap for Graduate Students on communicating their science & bringing their research from the bench to bedside. Immense thanks to Drs. Sandeep K. Mallipattu, Opeyemi Olabisi, & Lilia Cervantes

Day 3 of <a href="/ASNKidney/">American Society of Nephrology</a> STARS #KidneyWk program continuing with our special session Bridging the Gap for Graduate Students on communicating their science &amp; bringing their research from the bench to bedside. Immense thanks to Drs. <a href="/SKMallipattu/">Sandeep K. Mallipattu</a>, <a href="/OpeyemiOlabisi8/">Opeyemi Olabisi</a>, &amp; <a href="/Cervantes_Lily1/">Lilia Cervantes</a>
Gbadegesin Lab (@gbadegesinlab) 's Twitter Profile Photo

APOL1 variants and CKD in West Africa. One risk variant associated with FSGS and CKD. The story is getting more complex!! A call to sustain the momentum of cutting edge studies on APOL1 KD Opeyemi Olabisi Katalin Susztak SSC_Lab 🧬 Matt Sampson 🙏🏽

APOL1 variants and CKD in West Africa. One risk variant associated with FSGS and CKD. The story is getting more complex!! A call to sustain the momentum of cutting edge studies on APOL1 KD <a href="/OpeyemiOlabisi8/">Opeyemi Olabisi</a> <a href="/KSusztak/">Katalin Susztak</a> <a href="/SannaCherchiLab/">SSC_Lab 🧬</a> <a href="/kidneyomicsamps/">Matt Sampson</a> 🙏🏽